Class Action Lawsuit Alerts And News Information

Natrecor Lawsuit

Natrecor Side Effects

Natrecor is a purified preparation for human B-type natriuretic

peptide (hBNP) and is manufactured, using recombinant DNA technology, from E.

coil. The empirical formula for Nesiritide has is C143H244N50O42S4. It is

supplied in a single-use vial.

Netrecor is used to treat patients with acutely decompensated

congestive heart failure who have dyspnea at rest or patients who have

minimal activity. Treatment with Natrecor has reduced pulmonary capillary

wedge pressure and improved dyspnea in this sort of patients.

Netrecor is for intravenous use only and blood pressure should

be monitored closely during the administration of Netrecor. If during the

administration of Natrecor hypotension occurs, the dose is

Read more: Natrecor Lawsuit


Aldara Lawsuit

 Aldara is imiquimod cream. The

cream is an immune response modifier for topical

application. Aldara Cream is used:

·       For the surface of the affected area to treat

clinically typical, nonhyperkeratotic and nonhypertrophic

actinic keratoses on the face and scalp adults that are

immunocompetent

Read more: Aldara Lawsuit

Tamiflu Lawsuit

Tamiflu Side Effects

Tamiflu, an oseltamivir phosphate capsule used for oral solution, is used for the treatment of simple acute illness as a result of influenza infection in patients older than a year that have had symtoms for more than 2 days.

 Used as a prophylaxis of influenza in patients older than 1 year of age, it should be considered before treatment with Tamiflu is not a substitute for early vaccination yearly. Vaccination is recommended by the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices and can not be replaced by Tamiflu.  Resistance mutations can emerge and could decrease Tamiflu’s effectiveness as a result of the Influenza virus changing over time. Physicans should consider susceptibility patterns and the effects of treatment before deciding on whether to use Tamiflu on a patient.

Read more: Tamiflu Lawsuit

Serevent Diskus Lawsuit

Serevent Diskus Side Effects

              Servent Diskus, a salmeterol xinafoate inhalation powder, is a plastic inhalation delivery system that is specially designed containing a double foil blister strip of powder formulation used to treat asthma and to prevent bronchospasm in patients. The powder formulation consist of 50mcg sameterol assalmeterol xinafoate salt in 12.5mg of formulation containing milk protein.

Serevent Diskus is indicated for maintenance treatment of asthma and to prevent bronchospasm. Serevent Diskus can only be used in patients 4 years of age or older and who have reversible obstructive airway disease. This includes patients with symptoms of nocturnal asthma.

Read more: Serevent Diskus Lawsuit

Zelnorm Lawsuit

Zelnorm, a tegaserod maleate tablet, was approved in 2002 by the FDA and is used to treat constipated women with irritable bowel syndrome. In 2004 the approval was expanded to treat chronic constipation in both men and women younger than 65. The drug is no longer available in the U.S.

              The hydrogen maleate salt contained in Zelnorm is tegaserod.  tegaserod is chemically designated as 3-(5-methoxy-1H-indol-3-ylmethylene)-N-pentylcarbazimidamide hydrogen maleate. The drug’s empirical formula is C16H23N5O.C4H4O4 and the molecular weight is 417.47.

              As the maleate salt in Zelnorm, Tegaserod is a white to off-white crystalline powder and is soluble slightly in ethanol and even less soluble in water.  1.385mg of tegaserod as the maleate salt is equivalent to 1 mg of tegaserod.

              Zelnorm is available for oral use in the 2 mg and 6 mg tablets in blister packs containing 2 mg and 6 mg tegaserod and the following inactive ingredients:

·       lactose monohydrate

·       polyethylene glycol 4000

·       Crospovidone

·       glyceryl monostearate

·       hypromellose

·       poloxamer 188

Zelnorm is also available in 6mg tablets in prescription bottles containing 6mg tegaserod and the following inactive ingredients:

·       lactose monohydrate

·       colloidal silicon dioxide

·       crospovidone

·       glyceryl behenate

·       hypromellose

Zelnorm is used to treat patients less than 65 years of age with chronic idiopathic constipation and for the treatment of women with IBS. Zelnorm’s effectiveness in patients older than 65 years has not yet been established and its efficiency for treatment of IBS with constipation or chronic idiopathic constipation has not yet been studied beyond 12 weeks.

The recommended dose of Zelnorm for patients with Chronic Idiopathic Constipation is 6mg taken orally before meals twice daily. The need for continued therapy should be assessed periodically by patients and their physicians.

Read more: Zelnorm Lawsuit